Roivant Sciences Ltd. (ROIV)

Roivant Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 3, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	7,471	7,200	8,494	5,597	3,419	502
Market Cap Growth	-15.23%	-15.23%	51.75%	63.72%	580.90%	-
Enterprise Value	2,684	2,500	2,824	5,021	1,886	-326
Last Close Price	10.99	10.09	10.54	7.38	4.94	9.78
PE Ratio	-	-	1.95	-	-	-
PS Ratio	274.40	247.81	259.64	177.52	61.84	21.10
PB Ratio	1.63	1.39	1.32	3.48	1.66	0.24
P/TBV Ratio	1.59	1.54	1.42	5.53	2.06	0.28
EV/Sales Ratio	92.39	86.05	86.33	159.25	34.11	-
Debt / Equity Ratio	0.02	0.02	0.01	0.30	0.14	0.12
Asset Turnover	0.01	0.01	0.01	0.01	0.02	0.01
Quick Ratio	32.71	32.71	24.35	6.29	11.21	9.39
Current Ratio	33.47	33.47	25.24	6.60	11.64	9.99
Return on Equity (ROE)	-12.54%	-12.54%	112.87%	-48.46%	-44.82%	-43.17%
Return on Assets (ROA)	-10.73%	-10.73%	-10.14%	-20.33%	-20.26%	-11.71%
Return on Capital (ROIC)	-11.52%	-11.52%	-11.34%	-22.80%	-22.54%	-12.91%
Earnings Yield	-2.30%	-2.39%	51.20%	-18.03%	-24.72%	-161.17%
FCF Yield	-11.30%	-11.72%	-9.03%	-15.29%	-20.33%	-111.12%
Buyback Yield / Dilution	12.71%	12.71%	-16.59%	-6.43%	-6.30%	-187.64%

Updated May 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q